Skip to content
    UHS
    Earnings call· Mar 2026(Q1 FY26)

    UNIVERSAL HEALTH SERVICES Q1 FY26 earnings call UHS

    Apr 28, 2026 Source

    Executive summary

    Universal Health Services Q1 FY26 — Strong Performance with Talkspace Acquisition and AI Integration

    Universal Health Services delivered strong financial results in Q1 FY26, marked by significant revenue and earnings growth, alongside the strategic acquisition of Talkspace to bolster its behavioral health outpatient strategy. The company is actively integrating AI solutions to drive efficiency and enhance patient experience. Despite facing seasonal volume headwinds and ongoing shifts in health insurance exchange dynamics, management reiterated its full-year guidance, anticipating a ramp-up in earnings from new facility contributions and moderating wage pressures.

    Highlights

    5

    • Revenue growth for the first quarter was 9.6%.

    • Adjusted EBITDA net of NCI increased 8.4% in Q1 FY26.

    • Adjusted EPS increased 16.1% in Q1 FY26.

    • Talkspace acquisition expected to be accretive to earnings within 12 months post-closing, reaching a single-digit effective EBITDA multiple by year 3.

    • Cash generated from operating activities was $402 million, up from $360 million during the same period last year.

    Concerns

    5

    • Acute care volumes were impacted by approximately 200 basis points due to weaker flu and respiratory activity and winter weather.

    • Behavioral health volume growth was impacted by approximately 40 to 50 basis points due to winter weather.

    • Health insurance exchange trends are estimated to have a $15 million impact in Q1, with a reiterated full-year $75 million pretax impact.

    • Medicaid utilization saw slight declines in Q1.

    • Professional fees are rising at the high end of the single-digit range.

    Guidance & targets

    7
    CategoryTargetConfidence
    Full-year 2026 financial and operating forecasts
    Reiterated
    high materiality
    High
    Talkspace acquisition earnings accretion
    Accretive to earnings
    medium materiality
    High
    Talkspace acquisition effective EBITDA multiple
    Single-digit range
    medium materiality
    High
    Health insurance exchange trends pretax impact
    $75 million
    high materiality
    High
    Florida 2025 supplemental program benefit
    Estimated $50 million benefit
    medium materiality
    Medium
    New Florida hospital operating performance
    Operating loss for the year
    low materiality
    High
    Share buyback target
    $800 million to $900 million
    medium materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Acute Care Hospitals
    Same-facility net revenues increased 8.2%, or 6.2% excluding the impact of the health plan. Volumes were impacted by weaker flu/respiratory activity and winter weather. Positive trends observed in cardiology, orthopedics, and neurology service lines.
    Adjusted admissions: unchangedAdjusted admissions (ex-flu/weather impact): approximately 200 bps higherNevada market adjusted admissions: increased approximately 1.5%Emergency department visits: increased approximately by 2%Revenue per adjusted admission: increased 6.3%Revenue per adjusted admission (ex-supplemental program): up 4.9%Salaries, wages and benefits expense per adjusted admission: increased 3.1%Supply expense per adjusted admission: increased 3.5%Contract labor: 2.3% of revenues (40 bps lower year-over-year)
    		increased 8.2%8.2%—11.7% growth in same-facility segment EBITDA
    Behavioral Health
    Same-facility net revenues increased 7.3%. Volume growth was impacted by winter weather. Wage pressures are moderating, with salaries, wages, and benefits per adjusted patient day increasing by approximately 6% year-over-year, down from 7-8% in 2025.
    Revenue per adjusted patient day: 5.8% increaseAdjusted patient days: 1.6% increaseAdjusted patient days (ex-winter weather impact): approximately 40 to 50 bps higherRevenue per adjusted patient day (ex-supplemental payments): increased 4.9%Segment EBITDA (ex-supplemental payments): increased 4.3%Salaries, wages and benefits per adjusted patient day: increased by approximately 6%
    		increased 7.3%7.3%—8.4% in same-facility segment EBITDA

    Operational metrics

    14
    Adjusted EBITDA net of NCI growth
    8.4%YoY
    Q1 FY26
    Adjusted EPS
    $5.62increased 16.1%
    Q1 FY26

    Net income attributable to UHS per diluted share was $5.65 for Q1 FY26.

    Cash generated from operating activities
    $402 millionup from $360 million
    Q1 FY26

    Compared to the same period last year.

    Capital expenditures
    $217 million
    Q1 FY26
    Shares repurchased
    675,000
    Q1 FY26
    Share repurchase authorization remaining
    $1.3 billion
    As of March 31, 2026

    Pursuant to the stock buyback program.

    Credit facilities expansion
    $900 million
    Late April

    Expanded aggregate capacity to provide additional flexibility for Talkspace transaction, other potential acquisitions, and capital returns.

    Revolving credit facility outstanding
    $373 million
    As of March 31, 2026

    Borrowing capacity recently expanded to $1.5 billion.

    Acute care volumes impact from flu/weather
    200
    Q1 FY26

    Due to weaker flu and respiratory activity and winter weather in certain markets.

    Behavioral health volumes impact from weather
    40 to 50
    Q1 FY26
    Health insurance exchange impact
    $15 million
    Q1 FY26

    Estimated impact for Q1 FY26. Full year impact reiterated at $75 million pretax.

    Behavioral health salaries, wages and benefits per adjusted patient day growth
    6%YoY
    Q1 FY26

    Moderating slightly from the 7% to 8% level experienced during 2025.

    Professional fees growth
    high end of single digits
    FY26

    Management is working to keep these fees manageable through competitive coverage and reducing locums physicians.

    Florida 2025 supplemental program benefit
    $50 million
    FY25 program

    High confidence among providers for approval, but exact timing is unknown.

    Industry KPIs

    4
    MetricValueDetails
    Utilization trendsunchanged (acute care adjusted admissions); increased approximately by 2% (acute care ED visits); increased approximately 1.5% (Nevada market adjusted admissions); 1.6% increase (behavioral health adjusted patient days)%
    Same facility volumesunchanged (adjusted admissions); increased approximately by 2% (emergency department visits); increased approximately 1.5% (Nevada market adjusted admissions)%
    Payer mix supplemental payments$30 million (prior period supplemental program net benefit); $46 million (combined Nevada and Ohio out-of-period Medicaid supplemental payments)USD
    Adjusted EPS EBITDA leverage guidanceAdjusted EPS was $5.62; Adjusted EBITDA net of NCI increased 8.4%USD; %

    Deals & partnerships

    1
    TalkspaceAcquisition of a virtual outpatient behavioral health care platform, expanding UHS's continuum of services.

    Talkspace is an established market leader with a network of 6,000 licensed professionals serving all 50 states. It has a payer-driven business model. The acquisition was announced on March 9.

    Risks & headwinds

    4
    Weaker flu and respiratory activity and winter weather impact on volumesQ1 FY26

    Acute care volumes impacted by approximately 200 basis points; behavioral health volumes impacted by approximately 40 to 50 basis points.

    Mitigation: Expect same-facility growth to be more balanced between volume and pricing as the year progresses.

    Health insurance exchange trends and uncompensated careQ1 FY26 and full year 2026

    $15 million impact in Q1 FY26; full year $75 million pretax impact reiterated. Exchange adjusted admissions declined approximately 5%.

    Mitigation: Recorded additional reserve for HICS patients likely to lose coverage; investments in revenue cycle efficiency to keep pace with aggressive payer behavior.

    California nurse staffing ratio requirementsGo into effect June 1

    Not quantified, but noted as a significant operational change.

    Mitigation: Making good progress year-to-date and remain on track with assumptions contemplated in the 2026 outlook.

    Professional fee pressures from hospital-based physiciansOngoing

    Rising at the high end of the single-digit range.

    Mitigation: Being more competitive in terms of going out for coverage and trying to reduce the number of locums physicians.

    What to watch in Q2 FY26

    5

    Core EBITDA growth ramp

    Remainder of FY26
    Currentlow single-digit range for acute core EBITDA in Q1
    Targetcore level growth of 5% for full year

    Why it matters

    Management expects a significant ramp-up in core EBITDA growth to meet full-year guidance, driven by new facility contributions and moderating wage pressures.

    I think our overall results were within our expectations. And I think that implies that we expect a ramp in our earnings as the year goes on to get to that core level growth of 5% that's embedded in our guidance.

    Q&A highlights

    7

    Can you provide a sense of what the core EBITDA grew on the acute side, parsing out the impact of DPP, weather, and flu?

    Steve Filton stated that core EBITDA growth for the acute care segment was in the low single-digit range, acknowledging the complexity of parsing out various impacts.

    “Yes. I think it was in the low single-digit range, A.J.”

    asked by Albert Rice · answered by Steve Filton

    3 min read6 chapters

    Detailed Narrative

    01

    Talkspace Acquisition & Outpatient Strategy Expansion

    Universal Health Services announced the acquisition of Talkspace, a market leader in virtual outpatient behavioral health care with a network of 6,000 licensed professionals. This strategic move accelerates UHS's ability to create an end-to-end continuum of behavioral health services, from virtual outpatient to residential and inpatient care. The acquisition is expected to be accretive to earnings within 12 months post-closing and achieve a single-digit effective EBITDA multiple by year 3, driven by new outpatient revenue growth opportunities and bidirectional synergies, such as developing higher acuity virtual intensive outpatient programs (IOPs).

    02

    AI and Technology Adoption for Efficiency and Quality

    UHS is actively implementing enterprise-level AI solutions across its operations, focusing on both administrative efficiency and clinical quality/patient experience. In 2025, eight different AI use cases were deployed and scaled in revenue cycle operations, already yielding significant benefits. For 2026, the focus shifts to clinical operations, with several new use cases being designed and built in partnership with Hippocratic AI. These initiatives are expected to incrementally improve margins over time⏳ and have a real impact on quality and patient experience.

    03

    Q1 Volume and Pricing Dynamics

    The first quarter saw strong pricing contributions in both acute care and behavioral health segments, contributing to a 9.6% overall revenue growth. However, acute care volumes were negatively impacted by approximately 200 basis points due to weaker flu and respiratory activity and winter weather, while behavioral health volumes saw a 40-50 basis point impact from weather. Management anticipates same-facility growth to become more balanced between volume and pricing as the year progresses, expecting volume recovery after the seasonal impacts of Q1.

    04

    Medicaid Supplemental Payments and Core Growth Outlook

    UHS recorded significant prior-period Medicaid supplemental program net benefits in Q1, including approximately $30 million related to the expanded 2025 Nevada program and $46 million from combined Nevada and Ohio out-of-period📎 payments. While these were within expectations, management acknowledged that core EBITDA growth, excluding these non-recurring📎 items, was in the low single digits for acute care. The company expects a ramp-up in core earnings growth throughout the year, driven by the continued ramp-up of new facilities, growth in behavioral outpatient services, and moderating wage pressures.

    05

    Health Insurance Exchange Trends and Uncompensated Care

    Health insurance exchange adjusted admissions declined approximately 5% in Q1, leading to an estimated $15 million impact. UHS reiterated its full-year $75 million pretax impact from exchange trends, which assumes declines will steepen as the year progresses. The company has taken a conservative accounting position by recording an additional reserve for HICS patients who may not sustain premium payments, reflecting an effective HICS volume decline in the low double digits, largely impacting bad debt and uncompensated care.

    06

    Capital Investments and Facility Expansion

    UHS spent $217 million on capital expenditures in Q1 FY26, continuing its investment in strategic growth. Key projects include a 156-bed de novo hospital in Florida scheduled to open in May, and 178 new beds across two bed towers and a replacement hospital project in existing markets (California, Las Vegas, Florida) going online in Q2. In behavioral health, a 144-bed de novo joint venture hospital opened in Pennsylvania in early Q1, with another 120-bed de novo hospital planned for Missouri later this year.

    AI-generated summary of the company’s earnings call. Not investment advice.